JP2005151907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005151907A5 JP2005151907A5 JP2003397524A JP2003397524A JP2005151907A5 JP 2005151907 A5 JP2005151907 A5 JP 2005151907A5 JP 2003397524 A JP2003397524 A JP 2003397524A JP 2003397524 A JP2003397524 A JP 2003397524A JP 2005151907 A5 JP2005151907 A5 JP 2005151907A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- human
- human stem
- stem cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000130 stem cell Anatomy 0.000 description 74
- 210000004027 cells Anatomy 0.000 description 49
- 210000001691 Amnion Anatomy 0.000 description 20
- 210000002826 Placenta Anatomy 0.000 description 19
- 108091006028 chimera Proteins 0.000 description 18
- 210000000056 organs Anatomy 0.000 description 16
- 210000001161 Embryo, Mammalian Anatomy 0.000 description 15
- 210000001519 tissues Anatomy 0.000 description 11
- 102000004965 antibodies Human genes 0.000 description 10
- 108090001123 antibodies Proteins 0.000 description 10
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 9
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 9
- 101700068938 ZFP42 Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 101700033684 rex Proteins 0.000 description 9
- 210000003754 Fetus Anatomy 0.000 description 8
- 101710026246 POU5F1 Proteins 0.000 description 8
- 102100019163 POU5F1 Human genes 0.000 description 8
- 102000004058 Leukemia inhibitory factor Human genes 0.000 description 7
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 7
- 102000004142 Trypsin Human genes 0.000 description 7
- 108090000631 Trypsin Proteins 0.000 description 7
- 108091005938 enhanced green fluorescent protein Proteins 0.000 description 7
- 102000003995 transcription factors Human genes 0.000 description 7
- 108090000464 transcription factors Proteins 0.000 description 7
- 238000002054 transplantation Methods 0.000 description 7
- 229960001322 trypsin Drugs 0.000 description 7
- 239000012588 trypsin Substances 0.000 description 7
- 210000002798 bone marrow cell Anatomy 0.000 description 6
- 101700022010 TAP1 Proteins 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 210000000601 Blood Cells Anatomy 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 210000004748 cultured cells Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 210000003161 Choroid Anatomy 0.000 description 3
- 210000002219 Extraembryonic Membranes Anatomy 0.000 description 3
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 3
- 210000003494 Hepatocytes Anatomy 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000699660 Mus musculus Species 0.000 description 3
- 210000001178 Neural Stem Cells Anatomy 0.000 description 3
- 210000003491 Skin Anatomy 0.000 description 3
- 239000002771 cell marker Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000002257 embryonic structures Anatomy 0.000 description 3
- 230000003511 endothelial Effects 0.000 description 3
- 210000002919 epithelial cells Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 102100001249 ALB Human genes 0.000 description 2
- 101710027066 ALB Proteins 0.000 description 2
- 210000001643 Allantois Anatomy 0.000 description 2
- 210000004381 Amniotic Fluid Anatomy 0.000 description 2
- 210000001130 Astrocytes Anatomy 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N BRL-49594 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 101700033006 EGF Proteins 0.000 description 2
- 102100010813 EGF Human genes 0.000 description 2
- 229940116977 Epidermal Growth Factor Drugs 0.000 description 2
- 108050007372 Fibroblast growth factor family Proteins 0.000 description 2
- 102000018233 Fibroblast growth factor family Human genes 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- 102100005748 KRT18 Human genes 0.000 description 2
- 108010066327 Keratin-18 Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 210000002027 Muscle, Skeletal Anatomy 0.000 description 2
- 208000010125 Myocardial Infarction Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000008730 Nestin Human genes 0.000 description 2
- 108010088225 Nestin Proteins 0.000 description 2
- 102100005499 PTPRC Human genes 0.000 description 2
- 101700059076 PTPRC Proteins 0.000 description 2
- 229940049954 Penicillin Drugs 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 229960005322 Streptomycin Drugs 0.000 description 2
- 210000004304 Subcutaneous Tissue Anatomy 0.000 description 2
- 102100015249 VEGFA Human genes 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 2
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 2
- 229940050528 albumin Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229960000626 benzylpenicillin Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 210000002569 neurons Anatomy 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-[(1R)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
- 102100011550 ACTB Human genes 0.000 description 1
- 101700033661 ACTB Proteins 0.000 description 1
- 101710032514 ACTI Proteins 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 210000002459 Blastocyst Anatomy 0.000 description 1
- 210000001172 Blastoderm Anatomy 0.000 description 1
- 210000001109 Blastomeres Anatomy 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 210000001185 Bone Marrow Anatomy 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108060001251 CD34 Proteins 0.000 description 1
- 102100016492 CD34 Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920002676 Complementary DNA Polymers 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000033147 ERVK-25 Human genes 0.000 description 1
- 210000003981 Ectoderm Anatomy 0.000 description 1
- 210000001671 Embryonic Stem Cells Anatomy 0.000 description 1
- 210000004696 Endometrium Anatomy 0.000 description 1
- 210000003989 Endothelium, Vascular Anatomy 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 102100007406 FGF4 Human genes 0.000 description 1
- 101700036125 FGF4 Proteins 0.000 description 1
- 102100015612 FGF9 Human genes 0.000 description 1
- 101700084870 FGF9 Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 210000001654 Germ Layers Anatomy 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 102100019126 HBB Human genes 0.000 description 1
- 210000000777 Hematopoietic System Anatomy 0.000 description 1
- 108091005902 Hemoglobin subunit beta Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 210000004165 Myocardium Anatomy 0.000 description 1
- 210000004413 Myocytes, Cardiac Anatomy 0.000 description 1
- 102000002584 Octamer Transcription Factor-3 Human genes 0.000 description 1
- 108010068425 Octamer Transcription Factor-3 Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101710027269 PECAM1 Proteins 0.000 description 1
- 102100018954 PECAM1 Human genes 0.000 description 1
- 210000000496 Pancreas Anatomy 0.000 description 1
- 108091005771 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 101700031988 TAP2 Proteins 0.000 description 1
- 208000001608 Teratocarcinoma Diseases 0.000 description 1
- 210000001541 Thymus Gland Anatomy 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 210000003954 Umbilical Cord Anatomy 0.000 description 1
- 210000004291 Uterus Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 201000009030 carcinoma Diseases 0.000 description 1
- 210000002317 cardiac myocyte Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 210000001705 ectoderm cell Anatomy 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 210000004039 endoderm cell Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 230000002518 glial Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000001704 mesoblast Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000004255 neuroglia Anatomy 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 230000003169 placental Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001172 regenerating Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003397524A JP2005151907A (ja) | 2003-11-27 | 2003-11-27 | 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003397524A JP2005151907A (ja) | 2003-11-27 | 2003-11-27 | 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005151907A JP2005151907A (ja) | 2005-06-16 |
| JP2005151907A5 true JP2005151907A5 (fr) | 2006-02-02 |
Family
ID=34722656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003397524A Pending JP2005151907A (ja) | 2003-11-27 | 2003-11-27 | 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005151907A (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
| US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1349918B1 (fr) | 2000-12-06 | 2014-08-06 | Anthrogenesis Corporation | Technique de recueil de cellules souches placentaires |
| US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| ES2444548T3 (es) | 2001-02-14 | 2014-02-25 | Anthrogenesis Corporation | Renovación y repoblación de tejidos y órganos cadavéricos descelularizados por células madre |
| US7682803B2 (en) | 2005-10-13 | 2010-03-23 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
| CN101040042B (zh) | 2004-08-16 | 2013-06-19 | 细胞研究私人有限公司 | 自脐带羊膜分离干/祖细胞 |
| KR20080081088A (ko) | 2005-12-29 | 2008-09-05 | 안트로제네시스 코포레이션 | 태반 줄기세포와 제2 세포원으로부터 얻은 줄기세포의 공동배양 |
| CN103060263B (zh) | 2005-12-29 | 2016-03-16 | 人类起源公司 | 胎盘干细胞群 |
| CN103255098A (zh) | 2006-10-23 | 2013-08-21 | 人类起源公司 | 用胎盘细胞群治疗骨缺损的方法和组合物 |
| SI2120977T1 (sl) | 2007-02-12 | 2014-01-31 | Anthrogenesis Coroporation | Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic |
| KR20210127819A (ko) | 2007-09-28 | 2021-10-22 | 안트로제네시스 코포레이션 | 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법 |
| MX2011001991A (es) | 2008-08-20 | 2011-03-29 | Anthrogenesis Corp | Tratamiento de la apoplejia utilizando celulas placentarias aisladas. |
| CN105766891A (zh) | 2008-08-20 | 2016-07-20 | 人类起源公司 | 改进的细胞组合物及制备所述组合物的方法 |
| MX2011001992A (es) | 2008-08-22 | 2011-03-29 | Anthrogenesis Corp | Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias. |
| JP5869342B2 (ja) | 2008-11-19 | 2016-02-24 | アンスロジェネシス コーポレーション | 羊膜由来接着細胞 |
| CN102762720B (zh) | 2009-11-12 | 2015-03-11 | Vbi技术有限责任公司 | 类孢子细胞子群及其用途 |
| WO2011094181A1 (fr) | 2010-01-26 | 2011-08-04 | Anthrogenesis Corporation | Traitement de cancers associés aux os utilisant des cellules souches placentaires |
| PL2556145T3 (pl) | 2010-04-07 | 2017-02-28 | Anthrogenesis Corporation | Angiogeneza z zastosowaniem łożyskowych komórek macierzystych |
| WO2011127113A1 (fr) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Traitement de la sarcoïdose au moyen de cellules souches du sang placentaire |
| WO2012009422A1 (fr) | 2010-07-13 | 2012-01-19 | Anthrogenesis Corporation | Procédés de génération de cellules tueuses naturelles |
| MX357749B (es) | 2011-06-01 | 2018-07-23 | Anthrogenesis Corp | Tratamiento contra el dolor utilizando células madre placentarias. |
| EP3622960A1 (fr) | 2013-02-05 | 2020-03-18 | Celularity, Inc. | Cellules tueuses naturelles placentaires |
| WO2014132936A1 (fr) * | 2013-02-28 | 2014-09-04 | 国立大学法人 富山大学 | Procédé d'amplification sélective de cellules souches issues de tissus placentaires ou périplacentaires |
| JP6235795B2 (ja) * | 2013-05-29 | 2017-11-22 | 国立大学法人 東京医科歯科大学 | 細胞のリプログラミングのための組成物 |
| JP7454379B2 (ja) * | 2017-12-28 | 2024-03-22 | 株式会社カネカ | 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
-
2003
- 2003-11-27 JP JP2003397524A patent/JP2005151907A/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
| US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005151907A5 (fr) | ||
| JP2005151907A (ja) | 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法 | |
| JP4330995B2 (ja) | 絨毛膜絨毛、羊水、および胎盤からの胎児性幹細胞を単離、増殖、および分化させる方法、ならびにその治療的使用方法 | |
| US8268302B2 (en) | Cultures, products and methods using umbilical cord matrix cells | |
| JP4383896B2 (ja) | 脈管形成性の始原細胞をインビトロで同定し、単離し、または分化させるための新規な方法 | |
| US8597944B2 (en) | Culture systems for ex vivo development | |
| US20030161818A1 (en) | Cultures, products and methods using stem cells | |
| CN108431211A (zh) | 通过遗传编程的多谱系造血前体细胞产生 | |
| WO2016077273A1 (fr) | Manipulation de cellules souches mésenchymateuses par recombinaison homologue | |
| CN101792732A (zh) | 人多能干细胞生长和分化的技术 | |
| JPH05504066A (ja) | 遺伝子導入動物、それから得られる細胞および細胞系、およびその使用 | |
| JP2022105142A (ja) | 哺乳動物種における誘導組織再生のための組成物および方法 | |
| JP2012502653A (ja) | 人工多能性幹細胞のマーカー | |
| JP2003512052A (ja) | 分化前駆細胞及び系統欠失胚性幹細胞の産生方法 | |
| US20070202596A1 (en) | Selective antibody targeting of undifferentiated stem cells | |
| CN101065478B (zh) | 用于繁殖神经祖细胞的组合物和方法 | |
| JP2005520516A (ja) | 幹細胞の特定細胞系統への分化を誘発する方法 | |
| JP2003516141A (ja) | 長期細胞培養組成物とそれから誘導される遺伝的に修飾された動物 | |
| JP4153878B2 (ja) | Ｇｔ遺伝子が除去された複製豚及びその生産方法 | |
| CN113881624A (zh) | 一种细胞诱导的方法 | |
| Saxena et al. | Role of stem cell research in therapeutic purpose--a hope for new horizon in medical biotechnology. | |
| JP2005523685A (ja) | 体細胞由来胚幹細胞及びそれらの分化子孫 | |
| WO2005045007A1 (fr) | Procede et systeme pour stocker des cellules souches a l'etat congele | |
| JP2002176973A (ja) | 哺乳動物胚性幹細胞とその樹立方法並びにその継代培養方法 | |
| US20030109037A1 (en) | Methods for application of genetically-modified endogenous or exogenous stem/progenitor or their progeny for treatment of disease |